The funding will support the launch of the VERITAS trial while strengthening the company's clinical and regulatory ...

Field Medical announced today that it has closed a Series B funding round worth proceeds totaling $35 million.

Field Medical, Inc., a clinical-stage company redefining cardiac ablation with next-generation pulsed field ablation (PFA) ...

--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis ...

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device Provided by GlobeNewswire Jun 16, 2025, 11:00:00 AM ...

Modern technology is transforming the rehabilitation process from routine to fun. The use of gaming apps and virtual reality helps patients recover faster by combining therapeutic exercises with ...

The Stifel 2024 Cell Therapy Forum is a notable event in the field of cell therapy. ... at the forum will highlight Carisma Therapeutics’ ongoing efforts to advance cell therapy technologies.

Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation ...

Biomedical engineering is a field that employs quantitative methods in physics, chemistry and biology to develop innovative medical technologies. Skip to main content . Search. Enter the terms you ...

Panelists discuss how recent advancements in muscular dystrophy treatment have evolved toward truly disease-modifying therapies using gene replacement, antisense oligonucleotides, and gene ...